HK이노엔, 1분기 영업익 332억원…전년比 30.8% 증가

HK inno.N's significant year-over-year growth in operating profit signals robust operational efficiency and recovery within the pharmaceutical sector. This performance underscores the company's ability to sustain long-term growth momentum despite the quarter-over-quarter fluctuations commonly seen in the industry.